Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease Post author: Post published:April 25, 2024 Post category:uncategorized Funding represents the first time the foundation has taken an equity position in a breath diagnostics company. You Might Also Like US judge names receiver to take over California prisons’ mental health program March 20, 2025 What is the ‘immune self,’ and how can this concept benefit immunological research? May 13, 2024 From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech March 22, 2024